Datametrex Passes All Proposed Resolutions During The Annual General Meeting

Rhea-AI Summary

Datametrex AI (DTMXF) held its Annual General Meeting on November 13, 2024, with 17.15% of outstanding shares represented. Shareholders approved all proposed resolutions, including: fixing board directors at four members, re-electing directors, appointing Kingston Ross Pasnak as auditors, approving a name and symbol change, authorizing the sale of the Health Division, approving continuation from Ontario to British Columbia, approving common shares consolidation, and implementing an Omnibus Incentive Plan.

Positive

• Approval to sell Health Division, potentially streamlining operations
• Shareholders approved all proposed corporate restructuring initiatives
• Successfully secured approval for share consolidation, which could improve stock marketability

Negative

• Low shareholder participation rate of only 17.15% at AGM
• Pending share consolidation could lead to temporary stock price volatility

News Market Reaction

+43.42%

1 alert

+43.42% News Effect

On the day this news was published, DTMXF gained 43.42%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

TORONTO, ON / ACCESSWIRE / November 14, 2024 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) announces the voting results from the Annual General Meeting (the "Meeting") which was held on November 13, 2024.

At the Meeting, 17.15% of the issued and outstanding shares of the Company were represented. Details of all resolutions that were voted upon are set out in the Management Information Circular (the "Circular") dated October 2, 2024. The Circular is available on SEDAR (www.sedar.com).

With the approval of the shareholders at the meeting, all the resolutions were approved, including the below:

• fixing the number of directors at four (4);

• re-electing directors of the Company;

• appointing Kingston Ross Pasnak, LLP Chartered Professional Accountants as the auditors of the Company;

• approving the name change and stock symbol;

• authorizing the Corporation's sale of its Health Division;

• authorizing the Continuation from the Province of Ontario to the Province of British Columbia;

• approving consolidation of the Common Shares;

• approving the Omnibus Incentive Plan (the "Plan")

About Datametrex

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

For more on Datametrex, please visit our YouTube channel and Company website.

For Additional Information

Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to game development and other Company plans.

While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.

Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis for the year ended December 31, 2023, available on the Company's profile at www.sedarplus.ca.

This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.

SOURCE: DataMetrex AI Ltd.

View the original press release on accesswire.com

FAQ

What resolutions did Datametrex (DTMXF) pass at its November 2024 AGM?

Datametrex passed resolutions for board size fixing, director re-election, auditor appointment, name/symbol change, Health Division sale, provincial continuation to BC, share consolidation, and Omnibus Incentive Plan approval.

What was the shareholder participation rate at Datametrex's (DTMXF) 2024 AGM?

The shareholder participation rate at Datametrex's November 13, 2024 AGM was 17.15% of issued and outstanding shares.

Is Datametrex (DTMXF) selling its Health Division?

Yes, shareholders approved the authorization to sell the company's Health Division at the November 13, 2024 AGM.